bat
spit
drug
firm
goes
market
german
firm
whose
main
product
derived
saliva
vampire
bat
looking
raise
euros
â£m
stock
market
firm
paion
said
hoped
sell
million
shares
third
firm
euros
share
main
drug
desmoteplase
based
protein
bats
saliva
protein
stops
blood
clotting
helps
bat
drink
victims
could
also
used
help
stroke
sufferers
companys
shares
go
sale
later
week
scheduled
start
trading
frankfurt
stock
exchange
february
final
price
top
range
company
could
valued
much
euros
money
raised
spent
largely
developing
companys
drugs
since
desmoteplase
already
licensed
one
manufacturer
forest
laboratories
